Abstract
The coexistence of hypertension and diabetes synergistically increases the risk of cardiovascular and renal diseases. Although aggressive blood pressure reduction can decrease the rate of cardiovascular events in general, blockade of the renin-aldosterone-angiotensin system is a particularly effective target for antihypertensive treatment that may provide additional benefits for patients with diabetes. This article details evidence for blood pressure targets and antihypertensive drug choice in hypertensive patients with diabetes.